Register for the exhibition
about the Event
Where personal care ingredients and creators come together
Celebrating excellence in the field of ingredient innovation, in-cosmetics Korea also offers high-quality education on the latest science and trends. Plus, with targeted networking opportunities for the personal care ingredients community, you can uncover the tools to engage in new business and evolve your brand.
Due to the ongoing quarantine regulations in the context of the pandemic, we are unfortunately unable to participate in the physical in-cosmetics Korea this year. Together with the organizer, we have decided to participate virtually in this event and offer a webinar on Molecular Hiving™ technology on August 18th.
In this Bachem webinar, the speaker will guide you through the individual steps for synthesis of peptides applying Molecular Hiving™ technology. This approach is a tag-assisted liquid-phase peptide synthesis technology developed by Professor Kazuhiro Chiba at Tokyo University of Technology and Agriculture.
You will learn about the scalability and the substantial advantages of this technology regarding efficiency and towards greener manufacturing, as solvent consumption and material requirements are significantly reduced compared to conventional SPPS processes. Molecular Hiving™ also allows the synthesis of peptides without the use of solvents and reagents which are carcinogenic, mutagenic, or toxic to reproduction (CMR substances). This makes peptide products manufactured by this technology highly attractive for the pharmaceutical and cosmetics industry.
Bachem and its partner Jitsubo CO., LTD. signed of an exclusive Licensing Agreement for Jitsubo’s Molecular Hiving™ technology. Under the License agreement, Jitsubo develops selected manufacturing processes using their Molecular Hiving™ technology and transfer these processes to Bachem. Further optimizes, scale up and produce for commercial applications is done at Bachem.
Dr. Wolfgang Seufert
Dr. Wolfgang Seufert is a Director of Production at Bachem Bubendorf facility. At Bachem he is leading a team focusing on the scale-up development of manufacturing processes for peptides in solution. Having joined Bachem more than 13 years ago and working in several positions at the Bubendorf and Torrance facilities of Bachem, he has gained broad experience in development, scale up, and manufacturing of peptides, both LPPS and SPPS.
Wolfgang Seufert studied chemistry in Germany at the universities of Giessen and Leipzig. After earning his PhD from the University of Basel (Switzerland) for his work on cyclization reactions of modified amino acids and peptides, he worked as a post-doctoral fellow at the Life Sciences Institute of the University of Michigan (USA).
Stefanie Dobitz studied chemistry at the Justus Liebig University Giessen (Germany), receiving her M.Sc. for her work on stereoselective oxidations using peptide-based organocatalysts. She earned her doctoral thesis from ETH Zurich (Switzerland) studying the synthesis and biological evaluation of oligoproline-based peptide ligands for tumor targeting.
Stefanie joined Bachem AG (Bubendorf, Switzerland) in 2017. After increasing responsibilities in the Sales Department at Bachem, she became Group Leader Customer Synthesis Sales in 2019. In her role, Stefanie supports Bachem`s Asian and European customers with high quality peptides for cosmetics, in vitro diagnostics, and R&D.